Cell and Gene Therapy Market 2023 Analysis By Driving Factors, Growth Rate (26.21), Revenue, Trends & Forecast To 2032 | Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per the cell and gene therapy market report by The Business Research Company, Steady investment and consolidation in cell and gene therapies will continue to be a driver of the cell and gene therapy market. After recognising the potential of the CGT market, 16 out of the 20 largest biopharmaceutical companies by revenue, added CGT products to their portfolios. For instance, Merck invested $109 million in viral vector and gene therapy manufacturing in April 2020. Moreover, 12% of industrial clinical pipeline products and at least 16% of preclinical pipeline products consist of CGT. Steady investment and consolidation in CGT production capacity led to an increase in production capacity and also contributed to the growth of the market.

The global cell and gene therapy market grew from $8.57 billion in 2022 to $10.95 billion in 2023 at a compound annual growth rate (CAGR) of 27.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cell and gene therapy market is expected to grow from $26.21 billion in 2027 at a CAGR of 24.4%.

Read More On The Cell And Gene Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Major competitors in the Cell And Gene Therapy market include Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck.

The Cell And Gene Therapy market is segmented -
• By Product: Cell Therapy, Gene Therapy
• By Application: Oncology, Dermatology, Musculoskeletal, Other Applications
• By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Asia-Pacific was the largest region in the Cell And Gene Therapy market.

Request A Free Sample Of The Cell And Gene Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

Gene therapy involves the transmission of genetic material, typically in the form of a carrier or vector, and the uptake of the gene into the proper body cells. Cell therapy includes introducing cells into the patient with the appropriate function. Some procedures combine cell therapy with gene therapy.
The main types of products in cell and gene therapies are cell therapy and gene therapy. Gene therapy is a branch of medicine that focuses on modifying the genetic material of cells to achieve a therapeutic effect or to heal disease by repairing or reconstructing damaged genetic material. The different applications include oncology, dermatology, musculoskeletal, and others and involve various sectors such as hospitals, ambulatory surgical centers, cancer care centers, wound care centers, and others.

The Table Of Content For The Cell And Gene Therapy Market Include:
1. Executive Summary
2. Cell and Gene Therapy Market Characteristics
3. Cell and Gene Therapy Market Trends And Strategies
4. Cell and Gene Therapy Market - Macro Economic Scenario
5. Cell and Gene Therapy Market Size And Growth
……
27. Cell and Gene Therapy Market Competitive Landscape And Company Profiles
28. Cell and Gene Therapy Pipeline Analysis
29. Key Mergers And Acquisitions In The Cell and Gene Therapy Market
30. Cell and Gene Therapy Market Future Outlook and Potential Analysis
31. Appendix

The "Global Cell And Gene Therapy Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.